{{Rsnum
|rsid=3773814
|Gene=ATP2C1
|Chromosome=3
|position=130996904
|Orientation=plus
|GMAF=0.1079
|Gene_s=ATP2C1
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;C)
|geno3=(C;C)
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;C)
| geno3=(C;C)
| CEU | 75.2 | 21.2 | 3.5
| HCB | 77.6 | 21.6 | 0.7
| JPT | 81.4 | 18.6 | 0.0
| YRI | 100.0 | 0.0 | 0.0
| ASW | 96.5 | 3.5 | 0.0
| CHB | 77.6 | 21.6 | 0.7
| CHD | 70.6 | 28.4 | 0.9
| GIH | 75.0 | 22.0 | 3.0
| LWK | 0.0 | 0.0 | 0.0
| MEX | 77.2 | 21.1 | 1.8
| MKK | 0.0 | 0.0 | 0.0
| TSI | 82.4 | 17.6 | 0.0
| HapMapRevision=28
}}{{PMID Auto
|PMID=22285144
|Title=ATP13A2 (PARK9) polymorphisms influence the neurotoxic effects of manganese
|OA=1
}}

{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}